Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.70M | 4.75M | 774.26K | 619.02K | 406.68K | 40.26K | Gross Profit |
-600.45K | 334.63K | 242.73K | 250.05K | -3.28M | -2.75M | EBIT |
-5.62M | -2.56M | -7.34M | -6.91M | -5.01M | -3.76M | EBITDA |
-3.71M | -2.54M | -4.31M | -6.54M | -4.79M | -2.32M | Net Income Common Stockholders |
-4.75M | -3.20M | -5.04M | -6.95M | -5.06M | -2.62M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
854.11K | 584.02K | 1.98M | 2.94M | 8.96M | 428.03K | Total Assets |
1.82M | 3.73M | 3.13M | 4.55M | 9.49M | 2.08M | Total Debt |
22.65K | 3.20M | 1.69M | 2.16M | 709.34K | 1.16M | Net Debt |
-831.46K | 2.61M | -284.14K | -779.18K | -8.25M | 729.35K | Total Liabilities |
1.62M | 5.20M | 3.18M | 3.38M | 1.56M | 1.70M | Stockholders Equity |
205.82K | -1.47M | -46.86K | 1.17M | 7.92M | 386.86K |
Cash Flow | Free Cash Flow | ||||
-5.68M | -4.12M | -4.57M | -6.57M | -2.18M | -2.37M | Operating Cash Flow |
-5.65M | -4.10M | -4.51M | -6.51M | -2.13M | -2.31M | Investing Cash Flow |
-30.36K | -20.78K | -54.73K | -918.06K | -54.84K | -63.97K | Financing Cash Flow |
5.49M | 2.73M | 3.61M | 1.41M | 10.71M | 2.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $1.03B | ― | -19.56% | ― | 17.79% | 11.08% | |
59 Neutral | AU$18.38M | 140.00 | -3.11% | ― | 89.13% | 69.57% | |
51 Neutral | $5.32B | 3.32 | -40.25% | 2.90% | 17.93% | 2.14% | |
44 Neutral | AU$31.46M | ― | -31.58% | ― | 22.29% | 64.62% | |
40 Underperform | AU$9.23M | ― | ― | 18.53% | 33.17% | ||
39 Underperform | AU$29.22M | ― | -130.18% | ― | 3.37% | 47.32% | |
34 Underperform | $541.09M | ― | -133.28% | ― | 72.47% | 20.08% |
HITIQ Limited announced the issuance of 1,000,000 fully paid ordinary shares to fulfill investor relations services. This move, executed without disclosure under specific provisions of the Corporations Act, signifies HITIQ’s compliance with relevant regulatory requirements and reflects its strategic efforts to strengthen investor relations. The announcement underscores HITIQ’s commitment to transparency and adherence to corporate governance standards, potentially bolstering its market position and stakeholder confidence.
HITIQ Limited has drawn an additional $220,000 from its secured loan facility with Rockford RDF Pty Ltd, bringing the total to $1,020,000. This drawdown provides early access to their forecasted 2025 R&D Tax Incentive, with repayment expected upon receipt of the RDTI refund by the end of 2025. This financial maneuver is consistent with previous company announcements and reflects strategic financial planning to support ongoing operations.
HitIQ Limited has announced the quotation of 1,000,000 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective April 14, 2025. This move is part of a previously announced transaction and is expected to strengthen the company’s market presence and provide additional capital for its operations, potentially impacting stakeholders positively by enhancing the company’s financial flexibility.
HitIQ Limited has announced a proposed issue of 1,000,000 ordinary fully paid securities, with the issuance scheduled for April 14, 2025. This move is part of a placement or other type of issue, and the company has applied for the quotation of these securities on the ASX, which may impact its market presence and investor relations.
HITIQ Limited has issued 1,000,000 new ordinary shares to settle a $30,000 debt with an external Investor Relations service provider, using its ASX Listing Rule 7.1 placement capacity. This move reflects the company’s strategy to prioritize capital towards business operations, potentially impacting its financial management and stakeholder relations.
HitIQ Limited announced the cessation of 1,500,000 securities due to the expiry of options without exercise or conversion, effective March 25, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.
HitIQ Limited has announced a strategic shift towards the consumer market, specifically targeting amateur and community-level athletes with its HITIQ PROTEQT system. This move is supported by a three-year partnership with the Victorian Amateur Football Association (VAFA), positioning HitIQ as the official concussion technology partner. The partnership aims to leverage HitIQ’s elite-level technology to address the growing demand for concussion safety solutions among amateur athletes. By integrating their proven technology into an affordable product, HitIQ aims to drive adoption and achieve a cash flow positive future, ultimately enhancing player safety and expanding their market presence.
HitIQ Limited reported a reduction in revenues and an increase in losses for the half-year ended December 31, 2024, compared to the previous year. The company did not declare any dividends for this period, and its net tangible assets per share decreased significantly, indicating financial challenges that may impact its market position and stakeholder confidence.
HitIQ Limited has announced a proposed issue of securities, which includes issuing 14,700,000 performance rights and 800,000 fully paid ordinary employee shares. This strategic move is aimed at strengthening the company’s market position and supporting its growth objectives, potentially enhancing its competitive edge in the wearable sports technology sector.
HITIQ Limited has announced the establishment of a new loan facility agreement, providing early access to R&D expenditure for the 2025 financial year. The facility, amounting to $800,000, is structured with terms consistent with previous agreements, including a 15% interest rate and a maturity date 365 days from the agreement. This development is anticipated to bolster HITIQ’s operational capacity, potentially enhancing its industry standing by leveraging the funding for further innovation and market competitiveness.
HITIQ Limited has secured a loan facility with Rockford RDF Pty Ltd to gain early access to $800,000 from its forecast 2025 R&D Tax Incentive. This immediate fund access strengthens HITIQ’s financial position, allowing it to focus on its strategic priorities. The loan, based on incurred R&D expenses and expected tax incentives, will be repaid upon receiving the 2025 R&D Tax Incentive refund by December 2025.
HitIQ Limited announced the quotation of 5,248,043 fully paid ordinary securities on the ASX, effective from February 3, 2025. This move is part of previously announced transactions, and it signifies a strategic step in enhancing the company’s market presence and liquidity, potentially impacting investor interest and expanding its capital base.
HitIQ Limited has announced the appointment of Jennifer Tucker as a new director, effective February 1, 2025. This appointment does not involve any initial interests in securities or contracts, indicating a fresh start for Tucker in this role, potentially impacting the company’s strategic direction without prior encumbrances.
HITIQ Limited has appointed Jennifer Tucker to its Board as a Non-Executive Director, effective February 1, 2025. With extensive experience in the retail and consumer goods sector, Ms. Tucker is expected to enhance the company’s governance and strategic oversight, supporting HITIQ’s growth strategy in expanding its consumer offerings. This appointment reflects HITIQ’s dedication to strengthening its leadership team to advance its mission in concussion management technologies globally.
HitIQ Limited has announced a new securities issue with a maximum of 5,248,043 fully paid ordinary shares to be issued. This move is part of HitIQ’s strategy to strengthen its financial position and enhance its market presence. The announcement could have significant implications for the company’s operations and its stakeholders, as it suggests a potential increase in capital that may be used for further growth or investment opportunities.
HITIQ Limited announced that its largest shareholder, Harmil Angel Investments, intends to convert $1.6 million of convertible notes into ordinary shares, with a premium conversion price set above the initial discount. This conversion will require regulatory compliance and the issuance of an Independent Expert’s Report. Additionally, the company has revised its Corporate Advisory Mandate with Henslow Pty Ltd to attract US-based investors, and intends to settle debts with external service providers by issuing new shares, maintaining focus on operational capital prioritization.
HITIQ Limited has extended its partnership with the Premier League by 18 months, increasing the annual contract value by 60%. This extension underscores the effectiveness and growing adoption of HITIQ’s concussion management technology, enhancing the company’s footprint in elite sports. Additionally, HITIQ appointed Chris Davis as Chief Marketing Officer to bolster its global marketing strategy and secured an additional $3 million through a convertible note facility to support production, sales, and global commercialization efforts. These developments are set to strengthen HITIQ’s market position and support its growth ambitions in the concussion management space.